Title:
ＧＬＰ−１化合物の経口投薬
Document Type and Number:
Japanese Patent JP6672140
Kind Code:
B2
Abstract:
The present invention relates to improved uses of GLP-1 peptides in oral therapy.
More Like This:
| WO/2013/067022 | FORMULATIONS FOR THE TREATMENT OF DIABETES |
| JP6768515 | Double-acylated GLP-1 compound |
| WO/2011/087671 | OXYNTOMODULIN PEPTIDE ANALOGUE |
Inventors:
Fleming Seiel Nielsen
Pell Sauer Bali
Pell Sauer Bali
Application Number:
JP2016511088A
Publication Date:
March 25, 2020
Filing Date:
May 02, 2014
Export Citation:
Assignee:
Novo Nordisk Ar/S
International Classes:
A61K38/26; A61K9/20; A61K47/18; A61P3/04; A61P3/10
Domestic Patent References:
| JP2004521093A | ||||
| JP2013514324A |
Foreign References:
| WO2012080471A1 | ||||
| WO2013009545A1 | ||||
| WO2012140117A1 |
Other References:
Am.J.Clin.Nutr.,2010年,Vol.92,p.810-817
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe